1
Clinical Trials associated with Cipromedegib环咪德吉片在肿瘤患者中单次和多次给药的安全性及药代动力学研究的 I期临床试验
[Translation] Phase I clinical trial of safety and pharmacokinetics of single and multiple doses of cyclomidepime tablets in cancer patients
主要研究目的
1)考察环咪德吉在晚期实体瘤患者中的安全性和耐受性,确定剂量限制性毒性(DLT )及最大耐受剂量(MTD),推荐 II 期给药剂量; 2)考察环咪德吉的药代动力学特征;
次要研究目的
1)初步观察环咪德吉片的抗肿瘤疗效; 2)进行生物标记物的筛查。
[Translation] Main research objectives
1) To investigate the safety and tolerability of cyclomidagliptin in patients with advanced solid tumors, determine the dose-limiting toxicity (DLT) and maximum tolerated dose (MTD), and recommend the Phase II dosage; 2) To investigate the pharmacokinetic characteristics of cyclomidagliptin;
Secondary research objectives
1) To preliminarily observe the anti-tumor efficacy of cyclomidagliptin tablets; 2) To screen biomarkers.
100 Clinical Results associated with Cipromedegib
100 Translational Medicine associated with Cipromedegib
100 Patents (Medical) associated with Cipromedegib
100 Deals associated with Cipromedegib